132 related articles for article (PubMed ID: 28739303)
1. CpG oligonucleotides increase HBV-specific cytokine responses in whole blood and enhance cytokine release assay sensitivity.
Dammermann W; Dornbrack J; Bröker K; Bentzien F; Lüth S
J Virol Methods; 2017 Oct; 248():195-201. PubMed ID: 28739303
[TBL] [Abstract][Full Text] [Related]
2. Complement factors C3a and C5a mimick a proinflammatory microenvironment and increase HBV IGRA sensitivity.
Bröker K; Terzenbach R; Bentzien F; Lüth S; Dammermann W
J Transl Med; 2019 Jan; 17(1):6. PubMed ID: 30602374
[TBL] [Abstract][Full Text] [Related]
3. Development of a novel IGRA assay to test T cell responsiveness to HBV antigens in whole blood of chronic Hepatitis B patients.
Dammermann W; Bentzien F; Stiel EM; Kühne C; Ullrich S; Schulze Zur Wiesch J; Lüth S
J Transl Med; 2015 May; 13():157. PubMed ID: 25968473
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B surface antigen (HBsAg) and core antigen (HBcAg) combine CpG oligodeoxynucletides as a novel therapeutic vaccine for chronic hepatitis B infection.
Li J; Ge J; Ren S; Zhou T; Sun Y; Sun H; Gu Y; Huang H; Xu Z; Chen X; Xu X; Zhuang X; Song C; Jia F; Xu A; Yin X; Du SX
Vaccine; 2015 Aug; 33(35):4247-54. PubMed ID: 25858855
[TBL] [Abstract][Full Text] [Related]
5. Lentiviral vector encoding ubiquitinated hepatitis B core antigen induces potent cellular immune responses and therapeutic immunity in HBV transgenic mice.
Dai S; Zhuo M; Song L; Chen X; Yu Y; Zang G; Tang Z
Immunobiology; 2016 Jul; 221(7):813-21. PubMed ID: 26874581
[TBL] [Abstract][Full Text] [Related]
6. Vaccination with ubiquitin-hepatitis B core antigen-cytoplasmic transduction peptide enhances the hepatitis B virus-specific cytotoxic T-lymphocyte immune response and inhibits hepatitis B virus replication in transgenic mice.
Zhuo M; Song L; Tang Y; Dai S; Chen X; Yu Y; Zang G; Tang Z
Mol Med Rep; 2015 Sep; 12(3):3591-3598. PubMed ID: 26004262
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro.
Vincent IE; Lucifora J; Durantel D; Hantz O; Chemin I; Zoulim F; Trepo C
Antivir Ther; 2009; 14(1):131-5. PubMed ID: 19320247
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B Virus Surface Antigen Activates Myeloid Dendritic Cells via a Soluble CD14-Dependent Mechanism.
van Montfoort N; van der Aa E; van den Bosch A; Brouwers H; Vanwolleghem T; Janssen HLA; Javanbakht H; Buschow SI; Woltman AM
J Virol; 2016 Jul; 90(14):6187-6199. PubMed ID: 27099316
[TBL] [Abstract][Full Text] [Related]
9. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.
Zeng Z; Kong X; Li F; Wei H; Sun R; Tian Z
J Immunol; 2013 Oct; 191(8):4184-93. PubMed ID: 24048897
[TBL] [Abstract][Full Text] [Related]
10. Cytokine-dependent anti-viral role of CD4-positive T cells in therapeutic vaccination against chronic hepatitis B viral infection.
Ren F; Hino K; Yamaguchi Y; Funatsuki K; Hayashi A; Ishiko H; Furutani M; Yamasaki T; Korenaga K; Yamashita S; Konishi T; Okita K
J Med Virol; 2003 Nov; 71(3):376-84. PubMed ID: 12966542
[TBL] [Abstract][Full Text] [Related]
11. Strong and multi-antigen specific immunity by hepatitis B core antigen (HBcAg)-based vaccines in a murine model of chronic hepatitis B: HBcAg is a candidate for a therapeutic vaccine against hepatitis B virus.
Akbar SM; Chen S; Al-Mahtab M; Abe M; Hiasa Y; Onji M
Antiviral Res; 2012 Oct; 96(1):59-64. PubMed ID: 22884884
[TBL] [Abstract][Full Text] [Related]
12. Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection.
Martinet J; Leroy V; Dufeu-Duchesne T; Larrat S; Richard MJ; Zoulim F; Plumas J; Aspord C
Hepatology; 2012 Nov; 56(5):1706-18. PubMed ID: 22707082
[TBL] [Abstract][Full Text] [Related]
13. HBV-specific lymphoproliferative and cytokine responses in patients with chronic hepatitis B.
Vingerhoets J; Michielsen P; Vanham G; Bosmans E; Paulij W; Ramon A; Pelckmans P; Kestens L; Leroux-Roels G
J Hepatol; 1998 Jan; 28(1):8-16. PubMed ID: 9537868
[TBL] [Abstract][Full Text] [Related]
14. CpG oligodeoxynucleotide inhibits HBV replication in a hydrodynamic injection murine model.
Hu W; Huang H; Zhang TY; Mao YY; Wang XJ; Wang SQ
Antivir Ther; 2015; 20(3):289-95. PubMed ID: 25279542
[TBL] [Abstract][Full Text] [Related]
15. HBV vaccination and HBV infection induces HBV-specific natural killer cell memory.
Wijaya RS; Read SA; Truong NR; Han S; Chen D; Shahidipour H; Fewings NL; Schibeci S; Azardaryany MK; Parnell GP; Booth D; van der Poorten D; Lin R; George J; Douglas MW; Ahlenstiel G
Gut; 2021 Feb; 70(2):357-369. PubMed ID: 32229546
[TBL] [Abstract][Full Text] [Related]
16. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
[TBL] [Abstract][Full Text] [Related]
17. Cytokine and chemokine responses in the acute phase of hepatitis B virus replication in naive and previously vaccinated blood and plasma donors.
Keating SM; Heitman JD; Wu S; Deng X; Stramer SL; Kuhns MC; Mullen C; Norris PJ; Busch MP
J Infect Dis; 2014 Mar; 209(6):845-54. PubMed ID: 24158960
[TBL] [Abstract][Full Text] [Related]
18. Induction of humoral and cellular immune response to hepatitis B virus (HBV) vaccine can be upregulated by CpG oligonucleotides complexed with Dectin-1 ligand.
Ito H; Ando T; Nakamura M; Ishida H; Kanbe A; Kobiyama K; Yamamoto T; Ishii KJ; Hara A; Seishima M; Ishikawa T
J Viral Hepat; 2017 Feb; 24(2):155-162. PubMed ID: 27807909
[TBL] [Abstract][Full Text] [Related]
19. Cytokine release of peripheral blood mononuclear cells in children with chronic hepatitis B virus infection.
Hsu HY; Chang MH; Ni YH; Lee PI
J Pediatr Gastroenterol Nutr; 1999 Nov; 29(5):540-5. PubMed ID: 10554120
[TBL] [Abstract][Full Text] [Related]
20. Fibronectin EDA and CpG synergize to enhance antigen-specific Th1 and cytotoxic responses.
Julier Z; de Titta A; Grimm AJ; Simeoni E; Swartz MA; Hubbell JA
Vaccine; 2016 May; 34(21):2453-2459. PubMed ID: 27016652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]